Angiotensinogen Adjusts Its Shape to Complex with Renin and Modulate Blood Pressure

Aiwu Zhou,Robin W. Carrell,Michael P. Murphy,Zhenquan Wei,Yahui Yan,Peter L. D. Stanley,Penelope E. Stein,Randy J. Read
DOI: https://doi.org/10.1107/s0108767310099332
2010-01-01
Abstract:The LKB1 tumor suppressor kinase regulates activity of the AMPK family of kinases.LKB1 is activaty is regulated by the pseudokinase STRADa and the scaffolding protein MO25a through an unknown, phosphorylation-independent, mechanism.Here we describe the 2.65 Å structure of the heterotrimeric LKB1/STRADa/MO25a complex, revealing an unusual allosteric mechanism of LKB1 activation.STRADa adopts a closed conformation typical of active protein kinases, and binds LKB1 as a pseudosubstrate.STRADa binding, promotes the active conformation of LKB1, which is further stabilized by MO25a interacting with the LKB1 activation loop.This represents a previously undescribed mechanism of kinase activation that may be relevant to understanding the evolution of other pseudokinases.The structure also reveals how mutations found in Peutz-Jeghers syndrome and other cancers impair LKB1 function.The body text font is Times New Roman (size 9) with single spacing and full justification.The total allowed area is 8 x 24 cm.
What problem does this paper attempt to address?